Literature DB >> 16670831

Intravenous immunoglobulin in the treatment of resistant subacute cutaneous lupus erythematosus: a possible alternative.

Christos E Lampropoulos1, Graham R V Hughes, David P D' Cruz.   

Abstract

Subacute cutaneous lupus erythematosus (SCLE) is a common manifestation of systemic lupus erythematosus. In many cases it appears to be resistant to various systemic or topical treatments. Three cases of resistant SCLE with good response to intravenous immunoglobulin (IVIG) are described here suggesting that IVIG could be an alternative treatment in these patients.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16670831     DOI： 10.1007/s10067-006-0222-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


  13 in total

1.  Long term effectiveness of intravenous immunoglobulin in Churg-Strauss syndrome.

Authors:  M G Danieli; M Cappelli; G Malcangi; F Logullo; A Salvi; G Danieli
Journal:  Ann Rheum Dis       Date:  2004-12       Impact factor: 19.103

2.  The treatment of lupus nephritis.

Authors:  David P D'Cruz; Graham R V Hughes
Journal:  BMJ       Date:  2005-02-19

3.  Pregnant patient with dermatomyositis successfully treated with intravenous immunoglobulin therapy.

Authors:  M Mosca; F Strigini; A Carmignani; A D'ascanio; A R Genazzani; S Bombardieri
Journal:  Arthritis Rheum       Date:  2005-02-15

Review 4.  Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings.

Authors:  Richard D Sontheimer
Journal:  Autoimmun Rev       Date:  2004-11-12       Impact factor: 9.754

5.  Clinical, histological and immunopathological features of 58 patients with subacute cutaneous lupus erythematosus. A review by the Italian group of immunodermatology.

Authors:  A Parodi; M Caproni; C Cardinali; E Bernacchi; A Fuligni; G De Panfilis; C Zane; M Papini; F C Veller; M Vaccaro; P Fabbri
Journal:  Dermatology       Date:  2000       Impact factor: 5.366

Review 6.  IVIg therapy in autoimmunity and related disorders: our experience with a large cohort of patients.

Authors:  Yehuda Shoenfeld; Uriel Katz
Journal:  Autoimmunity       Date:  2005-03       Impact factor: 2.815

7.  Intravenous Immunoglobulins in MS.

Authors:  M Stangel; R Gold
Journal:  Int MS J       Date:  2005-04

Review 8.  High-dose intravenous immunoglobulins: an option in the treatment of systemic lupus erythematosus.

Authors:  E Toubi; A Kessel; Y Shoenfeld
Journal:  Hum Immunol       Date:  2005-04       Impact factor: 2.850

9.  High-dose immunoglobulin during pregnancy for recurrent neonatal haemochromatosis.

Authors:  Peter F Whitington; Judith U Hibbard
Journal:  Lancet       Date:  2004 Nov 6-12       Impact factor: 79.321

Review 10.  Efficacy and safety of intravenous immunoglobulin for immune-mediated skin disease: current view.

Authors:  Anita Ruetter; Thomas A Luger
Journal:  Am J Clin Dermatol       Date:  2004       Impact factor: 7.403
View more
  7 in total

Review 1.  Intravenous immunoglobulins for treatment of connective tissue diseases in dermatology.

Authors:  Lyubomir A Dourmishev; Dimitrina V Guleva; Ljubka G Miteva
Journal:  Wien Med Wochenschr       Date:  2017-09-01

Review 2.  Evidence for the use of intravenous immunoglobulins--a review of the literature.

Authors:  Shaye Kivity; Uriel Katz; Natalie Daniel; Udi Nussinovitch; Neophytos Papageorgiou; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

3.  Treatment of Cutaneous Lupus Erythematosus: Review and Assessment of Treatment Benefits Based on Oxford Centre for Evidence-based Medicine Criteria.

Authors:  R R Winkelmann; Grace K Kim; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2013-01

4.  In silico Analyses of Skin and Peripheral Blood Transcriptional Data in Cutaneous Lupus Reveals CCR2-A Novel Potential Therapeutic Target.

Authors:  Rama Dey-Rao; Animesh A Sinha
Journal:  Front Immunol       Date:  2019-03-29       Impact factor: 7.561

5.  Efficacy of Intravenous Immunoglobulin Monotherapy in Patients with Cutaneous Lupus Erythematosus: Results of Proof-of-Concept Study.

Authors:  Christa Ky; Brian Swasdibutra; Shaadi Khademi; Sheetal Desai; Vivian Laquer; Sergei A Grando
Journal:  Dermatol Reports       Date:  2015-03-16

Review 6.  Intravenous Immunoglobulins: Mode of Action and Indications in Autoimmune and Inflammatory Dermatoses.

Authors:  Lyubomir A Dourmishev; Dimitrina V Guleva; Ljubka G Miteva
Journal:  Int J Inflam       Date:  2016-01-18

Review 7.  Cutaneous lupus erythematosus: A review of the literature.

Authors:  Stephanie Clare Blake; Benjamin Silas Daniel
Journal:  Int J Womens Dermatol       Date:  2019-07-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.